Key Points It reported some highly encouraging news about its leading drug candidate. This is a flu treatment aimed at folks who can't or won't take vaccines. 10 stocks we like better than Cidara Therapeutics › The leading pipeline drug being developed by Cidara Therapeutics (NASDAQ: CDTX) got a real boost from a regulator on Thursday, and the biotech's share price moved accordingly. Cidara's stock closed the day more than 12% higher, during a session in which the bellwether S&P 500 (SNPINDEX: ^GSP ...